From the Department of Surgery, Mayo Clinic, Phoenix.
Mayo Clinic Alix School of Medicine.
Ann Plast Surg. 2021 Aug 1;87(2):144-149. doi: 10.1097/SAP.0000000000002667.
Same-day discharge after mastectomy is a recently described treatment approach. Limited data exist investigating whether same-day discharge can be successfully implemented in patients undergoing mastectomy with immediate implant-based breast reconstruction (IBR).
Patients having mastectomy with IBR from 2013 to 2019 were reviewed. Enhanced recovery with same-day discharge was implemented in 2017. Patient characteristics, oncologic treatments, surgical techniques, and 90-day postoperative complications and reoperations were analyzed comparing enhanced recovery patients with historical controls.
A total of 363 patients underwent nipple-sparing (214, 59%) or skin-sparing (149, 41%) mastectomy with 1-stage (270, 74%) or tissue expander (93, 26%) IBR. Enhanced recovery was used for 151 patients, with 79 of these patients (52%) discharged same-day. Overall, enhanced recovery patients experienced a significantly lower rate of 90-day complications (21% vs 41%, P < 0.001), including hematoma (3% vs 11%, P = 0.002), mastectomy flap necrosis (7% vs 15%, P = 0.02), seroma (1% vs 9%, P < 0.001), and wound breakdown (3% vs 9%, P = 0.05). Postoperative complication rates did not significantly differ among enhanced recovery patients discharged same day. Postoperative admissions significantly decreased after enhanced recovery implementation (100% to 48%, P < 0.001), and admitted enhanced recovery patients experienced a lower length of stay (1.2 vs 1.8, P < 0.001). Enhanced recovery patients experienced a lower incidence of ≥1 unplanned reoperation (22% vs 33%, P = 0.01); overall average unplanned and total reoperations did not significantly differ between groups.
In conjunction with enhanced recovery practices, same-day discharge after mastectomy with IBR is a safe and feasible treatment approach.
乳房切除术的当天出院是最近描述的一种治疗方法。关于在接受乳房切除术和即刻植入物乳房重建(IBR)的患者中是否可以成功实施当天出院,目前的数据有限。
回顾了 2013 年至 2019 年间接受 IBR 的乳房切除术患者。增强型恢复和当天出院是在 2017 年实施的。比较增强型恢复患者与历史对照患者的患者特征、肿瘤治疗、手术技术以及 90 天术后并发症和再手术。
共有 363 例患者接受了乳头保留(214 例,59%)或皮肤保留(149 例,41%)乳房切除术,采用 1 期(270 例,74%)或组织扩张器(93 例,26%)IBR。共有 151 例患者接受了增强型恢复,其中 79 例(52%)当天出院。总体而言,增强型恢复患者的 90 天并发症发生率明显较低(21%比 41%,P <0.001),包括血肿(3%比 11%,P = 0.002)、乳房切除术皮瓣坏死(7%比 15%,P = 0.02)、血清肿(1%比 9%,P <0.001)和伤口破裂(3%比 9%,P = 0.05)。当天出院的增强型恢复患者的术后并发症发生率没有显著差异。实施增强型恢复后,术后住院人数明显减少(100%至 48%,P <0.001),且住院增强型恢复患者的住院时间更短(1.2 天比 1.8 天,P <0.001)。增强型恢复患者发生≥1 次计划外再手术的发生率较低(22%比 33%,P = 0.01);两组之间的总体平均计划外和总再手术次数无显著差异。
与增强型恢复实践相结合,IBR 乳房切除术后当天出院是一种安全可行的治疗方法。